| SynergyFinder 2.0: visual analytics of multi-drug combination synergies A Ianevski, AK Giri, T Aittokallio Nucleic acids research 48 (W1), W488-W493, 2020 | 650 | 2020 |
| SynergyFinder: a web application for analyzing drug combination dose–response matrix data A Ianevski, L He, T Aittokallio, J Tang Bioinformatics 33 (15), 2413-2415, 2017 | 511 | 2017 |
| Discovery and development of safe-in-man broad-spectrum antiviral agents PI Andersen, A Ianevski, H Lysvand, A Vitkauskiene, V Oksenych, ... International Journal of Infectious Diseases 93, 268-276, 2020 | 239 | 2020 |
| Fully-automated and ultra-fast cell-type identification using specific marker combinations from single-cell transcriptomic data. TA Ianevski, Aleksandr, Anil K. Giri Nature communications 13 (1), 1-10, 2022 | 223* | 2022 |
| SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples A Ianevski, AK Giri, T Aittokallio Nucleic acids research 50 (W1), W739-W743, 2022 | 195 | 2022 |
| Integrated drug profiling and CRISPR screening identify essential pathways for CAR T-cell cytotoxicity O Dufva, J Koski, P Maliniemi, A Ianevski, J Klievink, J Leitner, P Pölönen, ... Blood, The Journal of the American Society of Hematology 135 (9), 597-609, 2020 | 173 | 2020 |
| Prediction of drug combination effects with a minimal set of experiments A Ianevski, AK Giri, P Gautam, A Kononov, S Potdar, J Saarela, ... Nature machine intelligence 1 (12), 568-577, 2019 | 124 | 2019 |
| Potential antiviral options against SARS-CoV-2 infection A Ianevski, R Yao, MH Fenstad, S Biza, E Zusinaite, T Reisberg, ... Viruses 12 (6), 642, 2020 | 120 | 2020 |
| Low temperature and low UV indexes correlated with peaks of influenza virus activity in Northern Europe during 2010–2018 A Ianevski, E Zusinaite, N Shtaida, H Kallio-Kokko, M Valkonen, A Kantele, ... Viruses 11 (3), 207, 2019 | 117 | 2019 |
| Obatoclax, saliphenylhalamide and gemcitabine inhibit Zika virus infection in vitro and differentially affect cellular signaling, transcription and metabolism S Kuivanen, MM Bespalov, J Nandania, A Ianevski, V Velagapudi, ... Antiviral research 139, 117-128, 2017 | 102 | 2017 |
| Screening of FDA-approved drugs using a MERS-CoV clinical isolate from South Korea identifies potential therapeutic options for COVID-19 M Ko, SY Chang, SY Byun, A Ianevski, I Choi, ... Viruses 13 (4), 651, 2021 | 92 | 2021 |
| Novel antiviral activities of obatoclax, emetine, niclosamide, brequinar, and homoharringtonine PI Andersen, K Krpina, A Ianevski, N Shtaida, E Jo, J Yang, S Koit, ... Viruses 11 (10), 964, 2019 | 92 | 2019 |
| Breeze: an integrated quality control and data analysis application for high-throughput drug screening S Potdar, A Ianevski, JP Mpindi, D Bychkov, C Fiere, P Ianevski, B Yadav, ... Bioinformatics 36 (11), 3602-3604, 2020 | 89 | 2020 |
| Novel activities of safe-in-human broad-spectrum antiviral agents A Ianevski, E Zusinaite, S Kuivanen, M Strand, H Lysvand, M Teppor, ... Antiviral research 154, 174-182, 2018 | 76 | 2018 |
| Common nodes of virus–host interaction revealed through an integrated network analysis K Bösl, A Ianevski, TT Than, PI Andersen, S Kuivanen, M Teppor, ... Frontiers in immunology 10, 2186, 2019 | 72 | 2019 |
| Identification and tracking of antiviral drug combinations A Ianevski, R Yao, S Biza, E Zusinaite, A Männik, G Kivi, A Planken, ... Viruses 12 (10), 1178, 2020 | 63 | 2020 |
| Expanding the activity spectrum of antiviral agents A Ianevski, PI Andersen, A Merits, M Bjørås, D Kainov Drug discovery today 24 (5), 1224-1228, 2019 | 48 | 2019 |
| Drug combinations as a first line of defense against coronaviruses and other emerging viruses JM White, JT Schiffer, RA Bender Ignacio, S Xu, D Kainov, A Ianevski, ... MBio 12 (6), e03347-21, 2021 | 47 | 2021 |
| SynToxProfiler: An interactive analysis of drug combination synergy, toxicity and efficacy A Ianevski, S Timonen, A Kononov, T Aittokallio, AK Giri PLoS computational biology 16 (2), e1007604, 2020 | 47 | 2020 |
| Antiviral properties of chemical inhibitors of cellular anti-apoptotic Bcl-2 proteins D Bulanova, A Ianevski, A Bugai, Y Akimov, S Kuivanen, H Paavilainen, ... Viruses 9 (10), 271, 2017 | 47 | 2017 |
